It is the first time scientists have shown that inhibiting an enzyme involved in programmed cell death can protect a brain region in a living animal from neurodegeneration following the withdrawal of steroids.
In addition, the University of Washington research being published in tomorrow's edition of the
Journal of Neuroscience reports that the infusion of this enzyme inhibitor into one brain region also kept another connected brain structure from degenerating.
The research has potential to help scientists develop clinical strategies for treating strokes and such human age-related degenerative diseases as Alzheimer's, Parkinson's and dementia, all of which may involve the death of brain cells.
Previous work by the co-authors Christopher Thompson and Eliot Brenowitz showed that neurons in a brain region called the HVC begin regressing within 12 hours after the withdrawal of the steroid hormone testosterone, followed soon thereafter by cell death. The new study indicates that enzymes called caspases, which play a key role in a cell suicide process called apoptosis, are involved in this process of neurodegeneration and that inactivation of caspases protects brain cells for at least a week.
Thompson, who just earned his doctorate in neurobiology and behavior at the UW and is now a postdoctoral researcher at the Freie Univeristät in Berlin, and Brenowitz, a UW professor of psychology and biology, study the brain regions controlling the singing behavior of a white-crowned sparrow.
"In the future, physicians might be able to stabilize people who have suffered a stroke using these inhibitors," said Brenowitz. "The basic mechanisms of cell death are the same in people and birds. With a stroke we often act as if it only affects the one area stricken by the loss of blood supply. But neuroscience has shown that different brain regions are connected in neural circuits. By using inhibitors like these to preserve neurons in the affected area, we might be able to preserve neurons in other connected brain areas."
The researchers received federal and state permits to capture 15 male sparrows in Eastern Washington after the breeding season as the birds were returning from Alaska to their winter home in California. The birds were housed indoors for 12 weeks under short-day lighting conditions to ensure their song and reproductive systems were regressed to a non-breeding state. Song-control regions in the brains of these sparrows and other songbirds naturally expand and shrink during the year depending on whether or not the birds are in a breeding state.
Next, the birds were exposed to 16 hours of light a day in long-day conditions, castrated and implanted with a high level of testosterone for 28 days to induce full growth of the song-control system. At that point, testosterone was withdrawn, the caspase inhibitors were infused near the HVC region on one side of the brain in 12 of the birds and the sparrows were returned to short-day lighting conditions. Three of the sparrows received a control substance that is chemically similar but did not have inhibitory properties. Groups of birds were euthanized after 1, 3 and 7 days. These procedures were done with the approval of the UW's Institutional Animal Care and Use Committee and the National Institute of Mental Health. The latter funded the research.
Examination of brain tissue showed that the caspase inhibitors prevented cell death in the HVC on the side of birds' brain that received these chemicals while this region began to degenerate on the opposite side of the brain. In addition, neurons in another connected song-control region called the RA on the side of the brain receiving the caspase inhibitors did not regress after seven days. Neurons in the HVC in the birds that did not get caspase inhibitors exhibited cell death, and RA neurons regressed.
"The normal role of hormones during the breeding season is to stimulate and maintain growth of these neural systems. We don't yet know all the ways in which hormones prevent brain cell death, but this study shows that hormones block caspases and so preserve neurons," said Brenowitz. "We are extending the life of these cells and halting the rapid degeneration of the song system."
Source: University of Washington
Related stories:
Cell death in sparrow brains may provide clues in age-related human diseases
A remarkable change takes place in the brains of tiny songbirds every year, and some day the mechanism controlling that change may help researchers develop treatments for age-related degenerative diseases of the brain such as Parkinson's and dementia.
Researcher determines link between foie gras and diseases
University of Tennessee Graduate School of Medicine professor and researcher Alan Solomon, M.D., director of the Human Immunology and Cancer/Alzheimer’s Disease and Amyloid-Related Disorders Research Program, led a team that discovered a link between foie gras prepared from goose or duck liver and the type of amyloid found in rheumatoid arthritis or tuberculosis.
Agonized pose tells of dinosaur death throes
The peculiar pose of many fossilized dinosaurs, with wide-open mouth, head thrown back and recurved tail, likely resulted from the agonized death throes typical of brain damage and asphyxiation, according to two paleontologists.
Researchers Discover How Brain Protein Might Control Memory
Researchers at Johns Hopkins have figured out how one particular protein contributes to long-term memory and helps the brain remember things longer than an hour or two. The findings are reported in two papers in the Nov. 9 issue of
Neuron.
Parsing the genome of a deadly brain tumor
The most comprehensive to-date genomic analysis of a cancer – the deadly brain tumor glioblastoma multiforme – shows previously unrecognized changes in genes and provides an overall view of the missteps in the pathways that govern the growth and behavior of cells, said members of The Cancer Genome Atlas Research Network in a report that appears online today in the journal
Nature.
Studies spot numerous undiscovered gene alterations in pancreatic and brain cancers
HHMI investigators have detected a multitude of broken, missing, and overactive genes in pancreatic and brain tumors, in the most detailed genetic survey yet of any human tumor. Some of these genetic changes were previously unknown and could provide new leads for improved diagnosis and therapy for these devastating cancers.
Surgical technique halts cell loss, Parkinson's researchers find
Deep brain stimulation, a surgical technique often viewed as a last resort for people with Parkinson's disease, halts the progression of dopamine-cell loss in animal models, according to preliminary research by scientists at the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital.
UC team studies link between Parkinson's disease and depression
A patient who receives a diagnosis of Parkinson's disease might become depressed, and understandably so. But does the depression then exacerbate the progression of Parkinson's?
